Skip to main content
OpenTrials

Clinical trial condition

AML Arising From Myelodysplastic Syndrome (MDS)

Explore clinical trials studying AML Arising From Myelodysplastic Syndrome (MDS). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

AML Arising From Myelodysplastic Syndrome (MDS) trial results

Active, Not Recruiting

Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation

NCT03173248

Conditions
AML Arising From Myelodysplastic Syndrome (MDS), Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Norton Cancer Institute - Suburban Louisville, Kentucky, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 90 locations
View Trial Details
Active, Not Recruiting

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

NCT02632708

Conditions
AML Arising After Exposure to Genotoxic Injury, AML Arising From Antecedent Hematologic Disorder (AHD), AML Arising From Myelodysplastic Syndrome (MDS), +9 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Chicago Chicago, Illinois, United States
View all 17 locations
View Trial Details

Related conditions